BeyondSpring Inc
BYSI
Company Profile
Business description
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Contact
100 Campus Drive, West Side
4th Floor, Suite 410
Florham Park
New JerseyNJ07932
USAT: +1 646 305-6387
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
40
Stocks News & Analysis
stocks
Tesla: Board announces new pay package for CEO Elon Musk
A key provision of the new award is that Musk must remain in a senior leadership position at Tesla.
stocks
Has the most hated company on the ASX 200 bounced back?
Encouraging results indicate a potential turnaround story.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,001.00 | 79.00 | 0.89% |
| CAC 40 | 7,632.01 | 85.85 | 1.14% |
| DAX 40 | 23,757.69 | 331.72 | 1.42% |
| Dow JONES (US) | 44,173.64 | 42.66 | 0.10% |
| FTSE 100 | 9,128.30 | 4.51 | -0.05% |
| HKSE | 24,733.45 | 39.88 | -0.16% |
| NASDAQ | 21,053.58 | 403.45 | 1.95% |
| Nikkei 225 | 40,556.62 | 265.92 | 0.66% |
| NZX 50 Index | 12,777.41 | 93.37 | 0.74% |
| S&P 500 | 6,329.94 | 91.93 | 1.47% |
| S&P/ASX 200 | 8,739.40 | 75.70 | 0.87% |
| SSE Composite Index | 3,583.31 | 23.36 | 0.66% |